Attribute Based Release

Attribute Based Release refers to a quality release strategy where a product batch is approved based on measured critical quality attributes rather than relying solely on end-product testing and traditional batch release models. This approach uses robust process understanding, validated analytical methods, and strong control strategies to demonstrate that manufacturing outputs consistently meet predefined quality requirements. Attribute based release aligns with modern quality principles by emphasising scientific evidence and process performance over reliance on extensive final product testing alone.

The biopharmaceutical industry increasingly explores attribute based release to improve efficiency, reduce release timelines, and enhance supply chain responsiveness for high demand therapies. Implementation requires extensive development work including defining critical quality attributes, establishing acceptance criteria, and validating real time or near real time testing approaches. Regulatory acceptance depends on demonstrating strong process capability, reliable analytical performance, and comprehensive lifecycle management plans. As continuous manufacturing and digital quality systems advance, attribute based release strategies are expected to expand, supporting faster patient access while maintaining stringent product quality and compliance expectations.